Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2021 | 7 |
2022 | 1 |
2024 | 0 |
Search Results
7 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Nivolumab + Ipilimumab for patients with hepatocellular carcinoma previously treated with Sorafenib.
Expert Rev Gastroenterol Hepatol. 2021 Jun;15(6):589-598. doi: 10.1080/17474124.2021.1899808. Epub 2021 Mar 19.
Expert Rev Gastroenterol Hepatol. 2021.
PMID: 33666530
Review.
Recent Advances and Future Prospects in Immune Checkpoint (ICI)-Based Combination Therapy for Advanced HCC.
Dong Y, Wong JSL, Sugimura R, Lam KO, Li B, Kwok GGW, Leung R, Chiu JWY, Cheung TT, Yau T.
Dong Y, et al. Among authors: kwok ggw.
Cancers (Basel). 2021 Apr 18;13(8):1949. doi: 10.3390/cancers13081949.
Cancers (Basel). 2021.
PMID: 33919570
Free PMC article.
Review.
Item in Clipboard
The Outcomes of Systemic Treatment in Recurrent Hepatocellular Carcinomas Following Liver Transplants.
Li BCW, Chiu J, Shing K, Kwok GGW, Tang V, Leung R, Ma KW, She WH, Tsang J, Chan A, Cheung TT, Lo CM, Yau T.
Li BCW, et al. Among authors: kwok ggw.
Adv Ther. 2021 Jul;38(7):3900-3910. doi: 10.1007/s12325-021-01800-z. Epub 2021 Jun 1.
Adv Ther. 2021.
PMID: 34061324
Item in Clipboard
Ipilimumab and nivolumab/pembrolizumab in advanced hepatocellular carcinoma refractory to prior immune checkpoint inhibitors.
Wong JSL, Kwok GGW, Tang V, Li BCW, Leung R, Chiu J, Ma KW, She WH, Tsang J, Lo CM, Cheung TT, Yau T.
Wong JSL, et al. Among authors: kwok ggw.
J Immunother Cancer. 2021 Feb;9(2):e001945. doi: 10.1136/jitc-2020-001945.
J Immunother Cancer. 2021.
PMID: 33563773
Free PMC article.
Item in Clipboard
A phase 1 study of pegylated recombinant arginase (PEG-BCT-100) in combination with systemic chemotherapy (capecitabine and oxaliplatin)[PACOX] in advanced hepatocellular carcinoma patients.
Yau T, Cheng PNM, Chiu J, Kwok GGW, Leung R, Liu AM, Cheung TT, Ng CT.
Yau T, et al. Among authors: kwok ggw.
Invest New Drugs. 2022 Apr;40(2):314-321. doi: 10.1007/s10637-021-01178-3. Epub 2021 Nov 4.
Invest New Drugs. 2022.
PMID: 34735674
Clinical Trial.
Item in Clipboard
The Use of Cabozantinib in Advanced Hepatocellular Carcinoma in Hong Kong-A Territory-Wide Cohort Study.
Wong JS, Dong Y, Tang V, Leung T, Yeung CSY, Tai A, Law A, Shum T, Kwok GG, Li BC, Leung R, Chiu J, Ma KW, She WH, Tsang J, Cheung TT, Yau T.
Wong JS, et al. Among authors: kwok gg.
Cancers (Basel). 2021 Apr 21;13(9):2002. doi: 10.3390/cancers13092002.
Cancers (Basel). 2021.
PMID: 33919277
Free PMC article.
Item in Clipboard
Thyroid Immune-Related Adverse Events in Patients with Cancer Treated with anti-PD1/anti-CTLA4 Immune Checkpoint Inhibitor Combination: Clinical Course and Outcomes.
Lui DTW, Lee CH, Tang V, Fong CHY, Lee ACH, Chiu JWY, Leung RCY, Kwok GGW, Li BCW, Cheung TT, Woo YC, Lam KSL, Yau T.
Lui DTW, et al. Among authors: kwok ggw.
Endocr Pract. 2021 Sep;27(9):886-893. doi: 10.1016/j.eprac.2021.01.017. Epub 2021 Feb 11.
Endocr Pract. 2021.
PMID: 33581327
Item in Clipboard
Cite
Cite